Versigent Reports Second Quarter 2026 Results
Versigent delivered Q2 2026 net sales of $2.44 billion, up 10.8% year-over-year, with Adjusted EBITDA rising 24.8% to $272 million and margins expanding by 120 basis points. The company raised and tightened its full-year 2026 net sales guidance to $9.40 billion to $9.60 billion, citing commodity pass-throughs and foreign currency impacts, while reaffirming Adjusted EBITDA and Free Cash Flow outlooks.
Key figures
- Eps
- 1.64
- Revenue
- $2,444 million
- Guidance
- FY26 Net sales $9,400 - $9,600 million (raised from $9,100 - $9,400 million)
- Revenue Yoy
- 10.8%
- Fcf
- 107
- Adjusted eps
- 1.92
- Adjusted ebitda
- 272
- Dividend per share
- 0.13
- Operating cash flow
- 158
- Adjusted ebitda margin
- 11.1%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.